Iridex Reports Q1 Revenue of $11.8M, Posts $500K Net Loss
IRIX sits 20% above its 52-week low of $0.869.
Summary
IRIDEX CORP announced its first-quarter 2026 financial results, reporting revenue of $11.8 million and a net loss of $500 thousand. The company also issued full-year 2026 revenue guidance, projecting between $51 million and $53 million. This update provides crucial new financial data following the full-year 2025 results detailed in the April 2, 2026 10-K filing. For a company of this size, the reported net loss is a material figure that traders will evaluate against market expectations. Investors will now focus on how these results and the forward guidance align with analyst consensus and the company's path to profitability.
At the time of this announcement, IRIX was trading at $1.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18.3M. The 52-week trading range was $0.87 to $1.65. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.